Navigation Links
Texas Cardiac Arrhythmia Institute at St. David's Medical Center Orders 4 Odyssey Systems
Date:9/15/2009

ST. LOUIS, Sept. 15 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS), announced that the Texas Cardiac Arrhythmia Institute at St. David's Medical Center in Austin, Texas ordered four Odyssey(TM) systems. One will manage its Niobe((R)) Remote Magnetic Navigation electrophysiology lab and the other three will manage its standard, non-Niobe EP labs. All four systems will utilize an Odyssey Cinema server to record synchronized procedure data and share this information via the Internet anywhere in the world.

Odyssey Cinema synchronizes the data from multiple interventional lab systems and includes a powerful archiving capability to instantly store and replay an integrated view of entire procedures or segments of procedures. The solution also allows physicians to collaborate with high-definition views of live or recorded procedures from multiple points in the network of installed Odyssey systems, providing a significant new tool for clinical collaboration, remote consultation, and educational training. There are currently more than 60 Odyssey systems ordered to date.

"Our vision is to use Odyssey to significantly accelerate the advancement of electrophysiology worldwide," said Andrea Natale, M.D., F.A.C.C., F.H.R.S., and Executive Medical Director of the Texas Cardiac Arrhythmia Institute at St. David's Medical Center. "With Odyssey, we have the technology to create unprecedented educational programs by sharing live cases over the network and by replaying best practices in interactive forums. Our connection to other centers on the Odyssey network will allow us to collaborate from Austin with other experts on a global basis without traveling. This creates a new standard for the practice of electrophysiology, unleashing new opportunities by allowing hospitals to have a powerful marketing tool and enabling patients on the Odyssey network to receive enhanced care around the world."

The Texas Cardiac Arrhythmia Institute at St. David's Medical Center will utilize the Odyssey network to connect with specific facilities around the world. Deliveries of the Odyssey systems to manage the standard EP labs will begin in the fourth quarter.

"This is the largest Odyssey order to date, and we are particularly excited by this opportunity to transform the EP department at the Texas Cardiac Arrhythmia Institute at St. David's Medical Center," said Michael P. Kaminski, Stereotaxis President and CEO. "We developed Odyssey to standardize data integration and management for all interventional labs and provide access to the live and recorded procedure information where and when it is needed. Through its proprietary data compression technology, the system enables sharing of this data with other interventional labs around the world via a secure Internet connection. With its unique capabilities, we anticipate that the Odyssey network will continue to establish a forum for defining clinical best practices across a broad spectrum of medical procedures."

About Odyssey

The Odyssey portfolio of products provides an innovative information backbone for managing, controlling, recording and sharing procedures performed in interventional labs. The Odyssey Workstation standardizes data integration for magnetic and standard interventional labs by enhancing the physician workflow through a consolidated display of multiple systems and eliminating the challenge of interacting simultaneously with many separate diagnostic systems. Odyssey Cinema then captures a complete record of synchronized procedure data that can be viewed live or from a comprehensive archive of cases performed. Through its proprietary data compression technology, the Odyssey enables the sharing of live and recorded procedure data via a laptop anywhere over a secure high speed Internet connection. Hospitals can also share procedures with other institutions using Odyssey Connect providing a forum for defining clinical best practices across a broad spectrum of medical procedures.

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe, and Canada and elsewhere.

About Forward Looking Statements

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance for the Company's products in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that we will recognize revenue related to our purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of our control. In addition, these orders and commitments may be revised, modified or canceled, either by their express terms, as a result of negotiations, or by project changes or delays.


'/>"/>
SOURCE Stereotaxis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
2. Texas Largest Physician Carrier Announces 5th Successive Rate Cut on Anniversary of Lawsuit Reform
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. South Texas Doctors Report More Severe Cases of Community Staph Super Bug Hospitalizing Children
5. Texas Aviation Services: Over 20 Years of Creating Flying Emergency Rooms for Airborne EMS Customers in US and Latin America
6. Dermatologists identify North Texas leishmaniasis outbreak
7. Precedent Launches Revolutionary Individual Health Insurance Plans in Texas
8. Health Care Service Corporation Provides Personal Clinical Summaries to Members of its Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas
9. Sesame Street Exhibition Makes Texas Premier at The Health Museum
10. The Law Offices of John David Hart: Texas Man Sues Medtronic in Body-Snatching Case
11. Viant Acquires Texas True Choice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  True Health, a ... amplified its effort during National Breast Cancer Awareness ... cancer risks. ... Oncology calculated that more than 10 million American ... mutations in BRCA1 or BRCA2 and have not had ...
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance ... a medical-grade battery-powered display stand specifically designed for endoscopy environments. An ... technology into a clinical solution to support the improvement of patient ... Innovative Design ... Wireless Solution ...
(Date:10/7/2017)...   Provista, a proven leader in the ... purchasing power, today announced a new resource area on ... is the online home for case studies, articles ... news releases, slideshows and events. ... resources at their fingertips, viewers can also watch short ...
Breaking Medicine Technology: